Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Share buy-back Fresenius Medical Care AG & Co. KGaA: Release of a capital market information 23.03.2020 / 17:56 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Share buy-back - 40th Interim Report In the period from March 16, 2020 until and including March 20, 2020, a total of 449,021 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF): XETRA  Aggregated volume in Weighted average share number of shares price in EUR Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 16.03.2020 344,779 56.40471 17.03.2020 9,953 59.2980 18.03.2020 9,187 58.8520 19.03.2020 3,000 58.3104 20.03.2020 990 57.3667   Chi-X Europe Day of repurchase Aggregated volume in number of sharesAggregated volume in number of sharesAggregated volume in number of shares Weighted average share price in EUR 16.03.2020 57,482 56.57144 17.03.2020 - - 18.03.2020 - - 19.03.2020 - - 20.03.2020 - -   BATS Europe Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 16.03.2020 9,652 56.4773 17.03.2020 - - 18.03.2020 - - 19.03.2020 - - 20.03.2020 - -   Turquoise Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 16.03.2020 13,978 56.3285 17.03.2020 - - 18.03.2020 - - 19.03.2020 - - 20.03.2020 - -   The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including March 20, 2020 therefore amounts to 5,903,049 shares. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., March 23, 2020 23.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News	DGAP News Service

1004339  23.03.2020